CareDx, Inc (CDNA) vs Pulse Biosciences, Inc. (PLSE)

A side-by-side comparison of CareDx, Inc and Pulse Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CDNA vs PLSE

growth of $100 · dividends reinvested · last 10y
CDNA +1824.2% (+34.4%/yr)PLSE +700.3% (+23.1%/yr)CDNA compounded faster over this window
05001k2k2k3kStart $10020182020202220242026$1,924$800
CDNA PLSE

CDNA vs PLSE: by the numbers

  • •PLSE is the larger company ($3.41B vs $3.34B market cap).
  • •CDNA is profitable (24.23% net margin) while PLSE runs a net loss (-6755.78%).

Metrics side by side

Valuation

MetricCDNAPLSE
P/E ratio31.20N/A
Forward P/E53.95N/A
P/S ratio7.302879.36
P/B ratio7.8634.29
EV / EBITDA192.12N/A
FCF yield2.54%N/A

Profitability

MetricCDNAPLSE
Gross margin70.58%-360.00%
Operating margin-0.92%-21982.57%
Net margin24.23%-6755.78%
ROE26.08%-80.46%
ROIC-0.93%-79.40%

Growth (annualized)

MetricCDNAPLSE
Revenue CAGR (5Y)12.56%N/A
Total return CAGR (5Y)1.33%19.76%

Frequently asked

Is CDNA or PLSE more profitable?
CDNA runs the higher net margin — CDNA at 24.23% versus PLSE at -6755.78%.
How have CDNA and PLSE total returns compared?
Over the past 10 years, CDNA delivered 34.41% and PLSE delivered 23.22% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.